These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11186701)

  • 1. [Effects of mineral water TIB-2 on metabolic processes in urolithiasis patients].
    Dzeranov NK; Beshliev DA; Golovanov SA; Kon'kova TA
    Urologiia; 2000; (3):15-7. PubMed ID: 11186701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrence-free and recurrent urolithiasis: metabolic differences].
    Konstantinova OV; Ianenko EK; Dzeranov NK
    Urologiia; 1999; (5):8-9. PubMed ID: 11150160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An efficacy study of the treatment of patients with chronic pyelonephritis and urolithiasis using sulfate-bicarbonate calcium-magnesium mineral water].
    Telina EN; Sakhabutdinov IuE; Mosikhina SS; Anisimova IV; Nizamova FA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (4):26-8. PubMed ID: 10513468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urinary uric acid levels in healthy subjects and in patients with urolithiasis.
    Sila-On A; Pavaro U; Nuchpramool W
    J Med Assoc Thai; 1991 Aug; 74(8):352-7. PubMed ID: 1791385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value attached to clinical laboratory findings in urolithiasis (author's transl)].
    Zechner O; Höltl G; Zekoff K; Zekert F
    Wien Klin Wochenschr; 1974 Nov; 86(21):654-7. PubMed ID: 4428778
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of biochemical methods in follow-up and treatment of patients with urolithiasis].
    Dzeranov NK; Konstantinova OV; Beshliev DA; Golovanov SA; Drozhzheva VV
    Urologiia; 2001; (1):18-20. PubMed ID: 11233224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urolithiasis in adults. Clinical and biochemical aspects.
    Abdel-Halim RE
    Saudi Med J; 2005 May; 26(5):705-13. PubMed ID: 15951854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of "Serebrianyĭ Kliuch" mineral water in the postoperative treatment of patients with nephrolithiasis after extracorporeal shock-wave lithotripsy].
    Neĭmark AI; Davydov AV
    Urologiia; 2003; (4):44-6. PubMed ID: 12942727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lithogenic elements in urine of healthy newborns.
    Cillo AC; Cattini H; Boim MA; Schor N
    Pediatr Nephrol; 2001 Dec; 16(12):1080-3. PubMed ID: 11793105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium hydrogen carbonate natural mineral water enriched with K(+)-citrate and vitamin B6 improves urinary abnormalities in patients with calcium oxalate nephrolithiasis.
    Bren A; Kmetec A; Kveder R; Kaplan-Pavlovcic S
    Urol Int; 1998; 60(2):105-7. PubMed ID: 9563149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes in various types of recurrent urolithiasis.
    Hrebícek J
    Acta Univ Palacki Olomuc Fac Med; 1992; 133():25-30. PubMed ID: 1344593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.